Veracyte EBITDA 2012-2025 | VCYT
Veracyte ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Veracyte Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $40 |
| 2023 | $-59 |
| 2022 | $-15 |
| 2021 | $-62 |
| 2020 | $-27 |
| 2019 | $-11 |
| 2018 | $-18 |
| 2017 | $-22 |
| 2016 | $-26 |
| 2015 | $-33 |
| 2014 | $-30 |
| 2013 | $-25 |
| 2012 | $-21 |
| 2011 | $-15 |
| Veracyte Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $8 |
| 2024-12-31 | $10 |
| 2024-09-30 | $18 |
| 2024-06-30 | $10 |
| 2024-03-31 | $1 |
| 2023-12-31 | $-29 |
| 2023-09-30 | $-24 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $1 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-9 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-43 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-5 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-4 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-9 |
| 2015-03-31 | $-8 |
| 2014-12-31 | $-8 |
| 2014-09-30 | $-8 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-7 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-6 |
| 2012-12-31 | |
| 2012-09-30 | $-5 |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.363B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.157B | 22.16 |
| Intuitive Surgical (ISRG) | United States | $171.022B | 70.89 |
| IDEXX Laboratories (IDXX) | United States | $52.319B | 54.45 |
| Edwards Lifesciences (EW) | United States | $45.899B | 30.42 |
| Alcon (ALC) | Switzerland | $42.809B | 28.93 |
| IQVIA Holdings (IQV) | United States | $32.198B | 18.19 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.060B | 32.12 |
| STERIS (STE) | Ireland | $24.242B | 25.80 |
| Waters (WAT) | United States | $17.472B | 24.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.672B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.441B | 26.82 |
| Masimo (MASI) | United States | $8.250B | 27.76 |
| Globus Medical (GMED) | United States | $8.125B | 18.70 |
| Teleflex (TFX) | United States | $5.369B | 8.67 |
| Glaukos (GKOS) | United States | $5.223B | 0.00 |
| TransMedics (TMDX) | United States | $4.423B | 67.22 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.956B | 16.92 |
| Alphatec Holdings (ATEC) | United States | $2.304B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.232B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.046B | 24.43 |
| Artivion (AORT) | United States | $2.027B | 102.26 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Pulse Biosciences (PLSE) | United States | $1.165B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.061B | 6.08 |
| IRadimed (IRMD) | United States | $0.892B | 43.30 |
| Beta Bionics (BBNX) | United States | $0.726B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.720B | 0.00 |
| AxoGen (AXGN) | United States | $0.686B | 0.00 |
| SiBone (SIBN) | United States | $0.660B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.549B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.520B | 4.18 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.509B | 8.98 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.50 |
| Pacific Biosciences Of California (PACB) | United States | $0.369B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 87.25 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| RxSight (RXST) | United States | $0.336B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.276B | 19.05 |
| Alpha Tau Medical (DRTS) | Israel | $0.271B | 0.00 |
| 908 Devices (MASS) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.235B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.207B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.092B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.16 |